The antiplasmodial activity of norcantharidin analogs.

[1]  A. McCluskey,et al.  Synthesis and biological activity of Delta-5,6-norcantharimides: importance of the 5,6-bridge. , 2010, European journal of medicinal chemistry.

[2]  I. Bertini,et al.  Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin. , 2009, Journal of medicinal chemistry.

[3]  B. Tekwani,et al.  Plasmodium falciparum serine/threonine phoshoprotein phosphatases (PPP): from housekeeper to the 'holy grail'. , 2008, Current drug targets.

[4]  E. Winzeler.  Malaria research in the post-genomic era , 2008, Nature.

[5]  M. Kizaki,et al.  Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway , 2008, Cancer science.

[6]  G. McFadden,et al.  Malaria: Differential parasite drive , 2007, Nature.

[7]  S. Ackland,et al.  Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation. , 2007, Bioorganic & medicinal chemistry.

[8]  B. Tekwani,et al.  A survey of synthetic and natural phytotoxic compounds and phytoalexins as potential antimalarial compounds. , 2007, Biological & pharmaceutical bulletin.

[9]  W. Boland,et al.  Intraspecific transfer of cantharidin within selected members of the family Meloidae (Insecta: Coleoptera). , 2007, Journal of insect physiology.

[10]  S. Ackland,et al.  Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity. , 2007, Bioorganic & medicinal chemistry letters.

[11]  G. Fall,et al.  Protein phosphatase 1, a Plasmodium falciparum essential enzyme, is exported to the host cell and implicated in the release of infectious merozoites , 2006, Cellular microbiology.

[12]  R. Coppel,et al.  A Maurer's cleft–associated protein is essential for expression of the major malaria virulence antigen on the surface of infected red blood cells , 2006, The Journal of cell biology.

[13]  R. Tarran,et al.  The Cystic Fibrosis Transmembrane Conductance Regulator Is Regulated by a Direct Interaction with the Protein Phosphatase 2A* , 2005, Journal of Biological Chemistry.

[14]  G. Tsokos,et al.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus. , 2005, The Journal of clinical investigation.

[15]  David A. Fidock,et al.  Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.

[16]  A. McCluskey,et al.  Modified norcantharidins; synthesis, protein phosphatases 1 and 2A inhibition, and anticancer activity. , 2004, Bioorganic & medicinal chemistry letters.

[17]  A. McCluskey,et al.  Protein phosphatase inhibition: structure based design. Towards new therapeutic agents. , 2004, Current pharmaceutical design.

[18]  C. van Hoof,et al.  Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question. , 2003, Biochimica et biophysica acta.

[19]  Adam McCluskey,et al.  Cantharidin analogues: synthesis and evaluation of growth inhibition in a panel of selected tumour cell lines. , 2003, Bioorganic chemistry.

[20]  A. McCluskey,et al.  Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies. , 2002, Journal of medicinal chemistry.

[21]  S. Ackland,et al.  Anticancer Activity and Protein Phosphatase 1 and 2A Inhibition of a New Generation of Cantharidin Analogues , 2002, Investigational New Drugs.

[22]  A. McCluskey,et al.  Small molecule inhibitors of serine/threonine protein phosphatases. , 2001, Mini reviews in medicinal chemistry.

[23]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[24]  T. Mészáros,et al.  Inhibition of serine/threonine-specific protein phosphatases causes premature activation of cdc2MsF kinase at G2/M transition and early mitotic microtubule organisation in alfalfa. , 2000, The Plant journal : for cell and molecular biology.

[25]  B. Hemmings,et al.  Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Nairn,et al.  A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A. , 1997, Bioorganic & medicinal chemistry.

[27]  M. Yanagida,et al.  The regulatory subunits of fission yeast protein phosphatase 2A (PP2A) affect cell morphogenesis, cell wall synthesis and cytokinesis , 1996, Genes to cells : devoted to molecular & cellular mechanisms.

[28]  G. Wang,et al.  Medical uses of mylabris in ancient China and recent studies. , 1989, Journal of ethnopharmacology.

[29]  L. C. Nickolls,et al.  Poisoning by Cantharidin , 1954, British medical journal.